611 W. Union Street
Benson, AZ 85602
(520) 586-0800

LaFrontera
member support line
1-520-279-5737
M-F 5pm-8pm
24/7 weekends/holidays

AzCH Nurse Assist Line
1-866-495-6735

NAZCARE Warm Line
1-888-404-5530



SEABHS
611 W. Union Street
Benson, AZ 85602
(520) 586-0800

AzCH Nurse Assist Line
1-866-495-6735

NAZCARE Warm Line
1-888-404-5530


powered by centersite dot net
Medical Disorders
Resources
Basic InformationLookupsLatest News
COVID Is Proving More Lethal for Children in Africa3 Reasons Why Trying to Get COVID Is a Bad IdeaFree N95 Masks Begin Arriving in U.S. PharmaciesOmicron Shows Signs of Ebbing as U.S. Cases Fall, Hospitalizations Level OffFDA Limits Use of Two COVID Antibody TreatmentsCOVID Can Affect Brains of Hospitalized KidsCOVID Vaccine Hesitancy Falling Faster Among Black Americans Than WhitesEngland to Lift Travel Restrictions for Vaccinated VisitorsAre Pins or a Cast Better for a Broken Wrist?FDA May Limit Use of Two COVID Antibody TreatmentsSome Patients With Macular Degeneration Could Stop Monthly Eye InjectionsYou Don't Have to Smoke to Get Lung CancerCOVID Vaccine Won't Affect Fertility, But Getting COVID MightThree New Studies Confirm Power of Booster Shots Against OmicronHit Your Head? Look for These Warning Signs of ConcussionArthritis & the COVID Vaccine: What You Need to KnowCOVID Boosters Keep Older Americans Out of Hospitals: CDCCOVID Rapid Test Makers Struggling to Meet DemandAHA News: A Healthy Thyroid Can Be Key to a Healthy HeartAnother Study Finds Vaccine Booster 'Neutralizes' Omicron'Artificial Pancreas' Can Help Kids With Type 1 DiabetesGetting Back to Sports After Recovering from COVID-19Side Effects From New Cancer Meds Have Silver LiningDengue Virus Makes Mosquitoes Bite More OftenNew Clues to Why Some Develop 'Brain Fog' After COVIDVaccination Plus Prior Infection Best Defense Against COVIDBinge-Watching Could Raise Your Blood Clot RiskIs a Night in the Hospital Necessary After Hip, Knee Replacement?Crowded Emergency Rooms Cost Lives: StudyCOVID Restrictions Eased in EnglandNo Side Effects From Your COVID Vaccine? Don't Worry, It's Still WorkingNearly Half of Americans Gained Weight in Pandemic's First YearNo Evidence Breastfeeding Can Transmit CoronavirusWHO Says Worst of Pandemic Could Ease This Year if Vaccine Inequities ErasedBiden Plans to Send 400 Million N95 Masks to Americans for FreeHeart Function Rebounds for Kids With COVID-Linked MIS-CAHA News: What Heart and Stroke Patients Need to Know About COVID-19 in 2022Which Kids Are Most Vulnerable to Severe COVID-19?Vaping Might Worsen COVID-19 SymptomsToo Soon to Tell if Omicron Will End Pandemic: FauciWhite House Launches Website for Free Home COVID Tests One Day Ahead of SchedulePolitics Clouds Folks' Views on COVID Rules, Global Survey ConfirmsCOVID-19 Treatments: What You Need to KnowAt-Home COVID Tests Accurate for Ki​ds: StudyHere's How to Get Your Free Home COVID Test KitsInsurance Often Covers Ivermectin for COVID, Even Though Drug Doesn't WorkCOVID Cases Surge Again in U.S. Nursing HomesCBD and Cannabis Products for Acne, Psoriasis? Buyer Beware, Dermatologists SayCarbon Monoxide Deaths Soar During Power OutagesAHA News: Transplanting Pig Hearts Into Humans Offers Promise – and Peril
Questions and AnswersLinksBook Reviews
Related Topics

Cancer
Men's Health
Women's Health

Exposure to Common Cold Might Help Shield Against COVID

HealthDay News
by Cara Murez
Updated: Jan 10th 2022

new article illustration

MONDAY, Jan. 10, 2022 (HealthDay News) -- Vaccination is still the best way to protect someone from COVID-19, but new research suggests that immune system activation of T-cells by common colds may offer some cross-protection.

The study might also provide a blueprint for a second-generation, universal vaccine that could prevent infection from current and future variants, the research team said.

"Being exposed to the SARS-CoV-2 virus doesn't always result in infection, and we've been keen to understand why. We found that high levels of preexisting T-cells, created by the body when infected with other human coronaviruses like the common cold, can protect against COVID-19 infection," said study first author Dr. Rhia Kundu, from Imperial College London's National Heart & Lung Institute, in the United Kingdom.

"While this is an important discovery, it is only one form of protection, and I would stress that no one should rely on this alone," Kundu added in a college news release. "Instead, the best way to protect yourself against COVID-19 is to be fully vaccinated, including getting your booster dose."

The study began in September 2020, when many people had neither been infected nor vaccinated, and included 52 people in the United Kingdom who lived with someone who had a SARS-CoV-2 infection and had been exposed. The participants took PCR tests after the exposure and again four to seven days later.

Their blood samples were taken within between one and six days of their exposure so that researchers could analyze the levels of pre-existing T-cells they had from previous common cold infections that also cross-recognized proteins of SARS-CoV-2.

The research team found significantly higher levels of these cross-reactive T-cells in the 26 people who did not become infected, compared to the 26 people who did.

To protect against SARS-CoV-2 infection, the T-cells targeted internal proteins within the virus, rather than the spike protein on the surface of the virus that helps it latch on to human cells.

Study limitations include that most of the participants were white Europeans. The findings were published online Jan. 10 in the journal Nature Communications.

Current COVID-19 vaccines don't induce an immune response to those proteins, so this offers a new vaccine target that could provide long-lasting protection, the researchers suggested. T-cell responses persist longer than antibody responses, which wane within a few months of vaccination.

"Our study provides the clearest evidence to date that T-cells induced by common cold coronaviruses play a protective role against SARS-CoV-2 infection. These T-cells provide protection by attacking proteins within the virus, rather than the spike protein on its surface," said senior study author Ajit Lalvani. He is director of the NIHR Respiratory Infections Health Protection Research Unit at Imperial.

"The spike protein is under intense immune pressure from vaccine-induced antibody which drives evolution of vaccine escape mutants. In contrast, the internal proteins targeted by the protective T-cells we identified mutate much less," Lalvani added in the news release. "Consequently, they are highly conserved between the various SARS-CoV-2 variants, including Omicron."

More information

The World Health Organization has more on COVID-19.

SOURCE: Imperial College London, news release, Jan. 10, 2022